|
The Merger Offer:
-
combines iSOFT’s innovative technology with Torex’s
proven domain expertise;
-
provides the opportunity to participate more fully in
the £2.3 billion NHS modernisation programme;
-
unites the two companies' international presence; and
-
enables the Merged Group to benefit from cost synergies and to capitalise on the
relative strengths of iSOFT and Torex.
The Merger Offer will be made to
acquire all Torex shares on the basis of 1.7692 new iSOFT shares for every Torex
share held
Full acceptance of the Merger Offer, would result in the issue to
Torex Shareholders of approximately 103.2 million New iSOFT Shares, representing
approximately 45.1 per cent of the enlarged issued share capital of iSOFT. On
the basis of the Closing Price of 346.0 pence per iSOFT Share on 24 September
2003 (the last business day prior to the issue of this announcement) the Merger
Offer values each Torex Share at approximately 612.1 pence and all of the
existing issued Torex Shares at approximately £337.5 million and the enlarged
iSOFT plc at £748.3million. |